Green tea catechins such as (-)-epicatechin and (-)-epigallocatechin accelerate Cu2+-induced low density lipoprotein oxidation in propagation phase

被引:86
作者
Yamanaka, N
Oda, O
Nagao, S
机构
[1] Bio-Dynamics Research Institute, Nagoya Memorial Hospital, Tenpaku-ku, Nagoya 468
关键词
catechin; antioxidant; oxidant; low density lipoprotein;
D O I
10.1016/S0014-5793(96)01455-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Effects of (-)-epicatechin (EC) and (-)-epigallocatechin (EGG) on Cu2+-induced low density lipoprotein (LDL) oxidation were studied in initiation and propagation phases, When 1.5 mu M EC or EGC was added to the mixture of isolated human LDL and Cu2+ in the initiation phase, the oxidation of LDL was inhibited in agreement with previous findings, In contrast, in the propagation phase, 1.5 mu M of EC or EGC worked as an accelerator of the oxidation, and acceleration ratios (maximum about 6 times) were modified depending on the concentrations of catechin used and the oxidation process in the propagation phase, The evidence was obtained from formation of thiobarbituric acid reactive substances (TBARS), detecting conjugated diene measured by absorbance at 234 nm and investigating fragmentation of apoprotein B (ape B) in LDL, Even in the propagation phase of LDL oxidation, the elevated concentrations of EC or EGC worked as inhibitors: after 40 min incubation of LDL with Cu2+, 10.0 mu M EC or 2.0 mu M EGC inhibited LDL oxidation, Yet, nitric oxide (NO) released from 5 mu M zwitterionic Polyamine/NO adducts had an inhibitory in all phases of LDL oxidation, These results indicate that catechins such as EC and EGC can act as free radical terminators (reducing agents) or accelerators (oxidizing agents) under oxidation circumstances, which is a different character from NO, From the above evidence, further investigations are needed on many natural flavonoids. the most potent antioxidative compounds in foods.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 21 条
[2]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[3]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[4]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[5]   ENHANCED MACROPHAGE DEGRADATION OF LOW-DENSITY LIPOPROTEIN PREVIOUSLY INCUBATED WITH CULTURED ENDOTHELIAL-CELLS - RECOGNITION BY RECEPTORS FOR ACETYLATED LOW-DENSITY LIPOPROTEINS [J].
HENRIKSEN, T ;
MAHONEY, EM ;
STEINBERG, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6499-6503
[6]   INHIBITION OF 1,2-DIMETHYLHYDRAZINE-INDUCED OXIDATIVE DNA-DAMAGE BY GREEN TEA EXTRACT IN RAT [J].
INAGAKE, M ;
YAMANE, T ;
KITAO, Y ;
OYA, K ;
MATSUMOTO, H ;
KIKUOKA, N ;
NAKATANI, H ;
TAKAHASHI, T ;
NISHIMURA, H ;
IWASHIMA, A .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (11) :1106-1111
[7]   MODIFICATION OF HUMAN-SERUM LOW-DENSITY-LIPOPROTEIN BY OXIDATION - CHARACTERIZATION AND PATHOPHYSIOLOGICAL IMPLICATIONS [J].
JURGENS, G ;
HOFF, HF ;
CHISOLM, GM ;
ESTERBAUER, H .
CHEMISTRY AND PHYSICS OF LIPIDS, 1987, 45 (2-4) :315-336
[8]   PROBUCOL PREVENTS THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBIT, AN ANIMAL-MODEL FOR FAMILIAL HYPERCHOLESTEROLEMIA [J].
KITA, T ;
NAGANO, Y ;
YOKODE, M ;
ISHII, K ;
KUME, N ;
OOSHIMA, A ;
YOSHIDA, H ;
KAWAI, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5928-5931
[9]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[10]   THE INHIBITION OF THE OXIDATION OF LOW-DENSITY-LIPOPROTEIN BY (+)-CATECHIN, A NATURALLY-OCCURRING FLAVONOID [J].
MANGIAPANE, H ;
THOMSON, J ;
SALTER, A ;
BROWN, S ;
BELL, GD ;
WHITE, DA .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (03) :445-450